These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38459425)

  • 21. [Effectiveness of statin treatment strategies for primary prevention of cardiovascular diseases in a community-based Chinese population: A decision-analytic Markov model].
    Gong C; Liu QP; Wang JM; Liu XF; Zhang ML; Yang H; Shen P; Lin HB; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):443-449. PubMed ID: 35701120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expert opinion: the therapeutic challenges faced by statin intolerance.
    Patel J; Martin SS; Banach M
    Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin Intolerance.
    Brown AS; Watson KE
    Rev Cardiovasc Med; 2018; 19(S1):S9-S19. PubMed ID: 30207553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Practical approach to statin intolerance].
    Štulc T; Beránková Š; Češka R
    Vnitr Lek; 2015 Nov; 61(11):936-41. PubMed ID: 26652780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin Intolerance: the Clinician's Perspective.
    Stulc T; Ceška R; Gotto AM
    Curr Atheroscler Rep; 2015 Dec; 17(12):69. PubMed ID: 26490078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current treatment of dyslipidaemia: PCSK9 inhibitors and statin intolerance.
    Koskinas K; Wilhelm M; Windecker S
    Swiss Med Wkly; 2016; 146():w14333. PubMed ID: 27400448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the management of statin myopathy.
    Gallo A; Perregaux J; Bruckert E
    Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):142-151. PubMed ID: 33278129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin Intolerance: an Overview of US and International Guidance.
    Cheeley MK; Clegg K; Lockridge C; Schubert TJ; Jones LK
    Curr Atheroscler Rep; 2023 Aug; 25(8):517-526. PubMed ID: 37410332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
    Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
    Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of statin-intolerant patient.
    Arca M; Pigna G; Favoccia C
    Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin Intolerance in Clinical Practice.
    Snejdrlova M; Altschmiedova T; Vrablik M; Stulc T; Lastuvka J; Lanska V; Ceska R
    Curr Atheroscler Rep; 2020 Jun; 22(7):27. PubMed ID: 32495058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Patients with Statin Intolerance in a Managed Care Plan: A Comparison of 2 Claims-Based Algorithms.
    Bellows BK; Sainski-Nguyen AM; Olsen CJ; Boklage SH; Charland S; Mitchell MP; Brixner DI
    J Manag Care Spec Pharm; 2017 Sep; 23(9):926-934. PubMed ID: 28854079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin Intolerance: A Review and Update.
    Tsushima Y; Hatipoglu B
    Endocr Pract; 2023 Jul; 29(7):566-571. PubMed ID: 36958647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin myopathy: over-rated and under-treated?
    Maghsoodi N; Wierzbicki AS
    Curr Opin Cardiol; 2016 Jul; 31(4):417-25. PubMed ID: 27258372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference.
    Mancini GB; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng D; Pope J
    Can J Cardiol; 2011; 27(5):635-62. PubMed ID: 21963058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements.
    Miller M; Tokgozoglu L; Parhofer KG; Handelsman Y; Leiter LA; Landmesser U; Brinton EA; Catapano AL
    Expert Rev Cardiovasc Ther; 2022 Aug; 20(8):609-625. PubMed ID: 35876118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherosclerotic cardiovascular disease risk assessment and predictors of statin use in Filipino-American Women.
    Borja-Hart N; Graff JC; Nolan VG; Wang J; Cooper-DeHoff RM; Ancheta IB
    J Clin Pharm Ther; 2019 Aug; 44(4):632-639. PubMed ID: 30963623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence.
    Tudor K; Brooks J; Howick J; Fox R; Aveyard P
    BMJ Open; 2020 Feb; 10(2):e033070. PubMed ID: 32051312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.